discoveri
sialic
acid
bovin
submaxillari
mucin
gave
first
glanc
uniqu
famili
sugar
play
import
role
wide
array
biolog
function
current
sialic
acid
sia
refer
famili
form
typic
vari
posit
figur
chief
among
mammalian
cell
nacetyl
neuramin
acid
ketoaldononuloson
acid
posit
termin
end
glycolipid
glycoprotein
sialyltransferas
respons
primarili
instal
termin
sia
glycoconjug
defin
glycosid
linkag
use
cytidin
cmp
sialic
acid
donor
natur
glycosid
linkag
involv
sialic
acid
depend
acceptor
sialoglycoconjug
commonli
link
galactos
nacetyl
galactosamin
polymer
form
sialyl
render
glycosid
linkag
postglycosyl
sialoglycoconjug
often
modifi
oacetyl
common
form
mammalian
cell
addit
form
postglycosyl
modif
increas
sia
divers
includ
omethyl
sulfat
phosphoryl
lactyl
oacetyl
form
sia
ubiquit
mammalian
cell
associ
structuretofunct
remain
incomplet
challeng
isol
character
oacetyl
sia
lead
insuffici
amount
materi
limit
biolog
meaning
studi
addit
oacetyl
often
lead
acetyl
migrat
proxim
hydroxyl
posit
add
complex
studi
compound
therefor
gener
synthet
standard
high
puriti
could
serv
use
tool
probe
function
signific
oacetyl
sia
oacetyl
occur
mono
di
tri
tetra
form
vari
posit
use
gaschromatographi
mass
spectrometri
gcm
nuclear
magnet
reson
nmr
spectroscopi
seri
oacetyl
sialoglycoconjug
extract
identifi
across
speci
tabl
common
form
oacetyl
across
speci
occur
posit
howev
oacetyl
directli
attach
pyranosyl
ring
also
feasibl
sialic
acidoacetyltransferas
soat
respons
sitespecif
oacetyl
soat
oacetyl
two
distinct
region
soat
ec
primarili
respons
oacetyl
extend
alkyl
chain
sia
ec
respons
oacetyl
posit
pyranosyl
ring
figur
although
soat
ec
well
document
structur
biolog
role
purif
isol
ec
unsuccess
studi
relat
remain
poorli
understood
soat
select
acetyl
migrat
within
extend
alkyl
chain
uncommon
lead
divers
oacetyl
form
schauer
cowork
show
soat
ec
incorpor
radioact
label
acetyl
coa
exclus
hydroxyl
posit
bovin
submandibular
gland
howev
prolong
incub
time
led
format
vliegenthart
cowork
also
observ
anoth
studi
oacetyl
migrat
bovin
submandibular
gland
glycoprotein
use
nmr
oacetyl
migrat
bacteri
system
howev
promiscu
less
predict
regard
n
meningitidi
acetyl
migrat
type
c
polysaccharid
occur
monitor
nmr
acetyl
group
serogroup
polysaccharid
contain
linkag
galactos
glucos
spontan
migrat
result
believ
oacetyl
product
acetyl
migrat
although
varki
cowork
specul
sialoglycoconjug
golgi
may
oacetyl
exclus
differ
soat
recent
gilbert
cowork
support
idea
nmr
studi
soat
identifi
c
jejuni
exclus
oacetyl
hydroxyl
group
studi
suggest
acetyl
migrat
proxim
hydroxyl
group
appear
spontan
oacetyl
group
remain
unaffect
oacetyl
soat
sitespecif
biolog
function
base
posit
acetyl
group
much
focu
revolv
around
oacetyl
posit
due
high
abund
across
speci
although
garner
attent
recent
context
viru
bind
viral
infect
viral
glycoprotein
recogn
sia
receptor
determin
prompt
entri
exit
host
cell
seen
certain
viru
speci
recognit
sialoglycoconjug
defin
linkag
isoform
appar
hemagglutinin
ha
influenza
b
virus
exampl
util
sialoglycoconjug
attach
hemagglutininneuraminidas
glycoprotein
respiroviru
util
sialoglycoconjug
attach
meanwhil
coronavirus
positivesens
singl
strand
rna
viru
classifi
famili
coronavirida
contain
spike
glycoprotein
hemagglutininesteras
util
oacetyl
form
sia
attach
viral
fusion
host
membran
promot
viral
replic
releas
dictat
receptordestroy
enzym
includ
sialidas
neuraminidas
hemagglutininesteras
depend
viru
type
viral
pathogen
therefor
requir
specif
partnership
believ
sia
glycosyl
pattern
critic
featur
viru
bind
howev
recognit
modifi
sia
appear
equal
import
specif
oacetyl
vari
site
sia
ie
vs
influenc
viru
recognit
attach
viral
receptor
molecul
show
remark
specif
toward
host
sialic
acid
isoform
molecular
level
delv
deeper
effect
oacetyl
siavir
enzym
may
help
identifi
potenti
therapeut
target
prevent
virusrel
diseas
sitespecif
oacetyl
sialoglycoconjug
found
across
varieti
speci
oacetyl
instanc
found
human
gut
rang
figur
meanwhil
oacetyl
ubiquit
ungul
echinoderm
australian
monotrem
echidna
subgroup
chordat
among
sever
vertebr
found
mostli
circulatori
system
fish
enzymat
mildli
acid
hydrolyt
releas
mucin
convent
method
partial
oacetyl
extract
prior
character
conveni
isol
techniqu
involv
applic
sialidas
howev
issu
relat
manufactur
cost
activ
without
jeopard
integr
oacetyl
group
prevent
access
materi
commerci
scale
among
detect
strategi
histochem
stain
becom
wide
accept
techniqu
detect
oacetyl
inform
sitespecif
tabl
ravindranath
cowork
instanc
show
radiolabel
purifi
crab
lectin
cancer
antennariu
incub
erythrocyt
tri
buffer
salin
bound
oacetyl
use
radiolabel
assay
recent
advanc
use
matrixassist
laser
desorptionion
mass
spectrometri
maldi
combin
imag
softwar
enabl
map
local
oacetyl
gangliosid
furthermor
modern
techniqu
avail
analys
includ
fluoresc
detect
analog
use
highperform
liquid
chromatographi
colorimetr
determin
thinlay
chromatographi
electrosprayion
mass
spectrometri
gcm
silyl
analogu
nmr
capsular
polysaccharid
cp
streptococcu
sui
respons
caus
mening
jin
cowork
found
partial
oacetyl
cmp
eg
use
glycosyl
donor
rather
free
cmp
sialic
acid
sever
strain
gramneg
bacteria
sui
e
coli
agalactia
modul
cp
bifunct
genet
code
neua
encod
synthetaseoacetylesteras
activ
figur
reason
bacteria
util
partial
oacetyl
substrat
cmp
synthetas
css
deoacetyl
still
investig
nonetheless
studi
suggest
oacetyl
exclus
postglycosyl
modif
rather
use
directli
substrat
glycosyl
although
oacetyl
form
investig
recent
chen
group
demonstr
feasibl
oacetyl
substrat
cmp
activ
use
css
neisseria
meningitidi
mutant
pasteurella
multocida
haemophilu
ducreyi
upon
cmp
activ
sialyltransferas
abl
uptak
cmp
render
link
sialoglycoconjug
without
compromis
acetyl
group
consid
eukaryot
system
oacetyl
colon
mucin
glycoprotein
human
colon
cell
line
ubiquit
corfield
cowork
show
inhibit
b
bifidum
sialidas
activ
oacetyl
interestingli
inhibitori
effect
increas
amount
oacetyl
group
increas
dioacetyl
incub
bacteri
sialidas
sialic
acid
cleavag
decreas
twofold
compar
mono
oacetyl
form
saponif
condit
deoacetyl
led
increas
releas
sialic
acid
sialidas
suggest
presenc
oacetyl
group
inhibit
bacteri
sialidas
activ
although
remain
unclear
whether
oacetyl
exhibit
similar
function
sinc
discoveri
oacetyl
blix
cowork
pepper
report
effect
oacetyl
viru
hemagglutininneuraminidas
activ
concern
hors
serum
account
approxim
total
sialyl
confirm
structur
elucid
use
thinlay
chromatographi
ga
chromatographi
period
oxid
studi
reveal
found
exclus
inhibit
hemagglutinin
influenza
strain
treatment
naoh
gave
slow
complet
loss
hemagglutinin
inhibit
presum
due
loss
oacetyl
group
furthermor
pepper
one
first
demonstr
select
reaction
viral
bacteri
neuraminidas
signific
find
sinc
indic
oacetyl
sia
determin
provid
specif
function
tabl
ad
inhibitori
effect
also
implic
facilit
initi
attach
virus
target
cell
similar
influenza
c
viru
infecti
salmon
anemia
viru
isav
classifi
orthomyxovirida
famili
contain
spike
glycoprotein
hemagglutininesteras
fusion
hef
protein
mediat
viru
entri
exit
exhibit
hemagglutin
receptor
destroy
activ
defin
major
receptor
determin
influenza
c
viru
recogn
isav
select
receptor
bind
destroy
activ
despit
known
similar
influenza
c
viru
receptor
destroy
enzym
display
acetylesteras
activ
cleav
oacetyl
group
high
specif
regard
case
isav
cleav
via
high
turnov
rate
deoacetyl
requir
substanti
extend
incub
time
furthermor
abolish
hemagglutin
inhibit
observ
guinea
pig
hors
sera
subject
saponif
condit
eg
n
naoh
rat
serum
exhibit
effect
significantli
studi
provid
evid
molecular
specif
depend
posit
acetyl
group
vs
highlight
import
enzym
mediat
function
appear
tailor
specif
oacetyl
express
profil
sia
seen
anoth
case
toro
coronavirus
coronavirida
famili
display
remark
receptor
bind
specif
oacetyl
sia
determin
virus
contain
glycoprotein
mediat
viru
entri
exit
similar
influenza
c
viru
hef
murin
coronavirus
display
activ
consist
observ
enzym
acquir
via
horizont
gene
transfer
thu
murin
coronaviru
he
recogn
sia
determin
howev
subset
murin
coronaviru
fail
recogn
specif
mous
hepat
viru
mhv
dvimstrain
recogn
mhv
sstrain
evolv
display
strong
bind
prefer
toward
ligand
crystal
structur
mhv
dvimh
close
resembl
overal
architectur
coronavirusmebu
bcovmebu
favor
bind
ligand
eloop
mhv
resembl
bcovmebu
chang
loop
respons
present
preferenti
bind
one
oacetyl
sia
form
anoth
specif
hydrophob
pocket
accommod
n
oacetyl
group
mutat
accommod
n
group
conform
shift
respons
primarili
chang
receptor
specif
mhv
dvimstrain
although
reason
chang
distinct
mhv
lineag
remain
ambigu
author
propos
evolutionari
chang
accommod
receptor
remain
neutral
indic
plastic
may
lead
resist
treatment
inhibit
sialidas
activ
modifi
sia
also
involv
nonviru
mediat
phenomena
mechan
surviv
milk
serv
sourc
nutrient
bioactiv
compon
offspr
earli
develop
howev
platypus
secret
milk
skin
pose
high
risk
pathogen
infect
thu
platypus
produc
oacetyl
sia
elev
amount
variant
sialic
acid
shown
interfer
recognit
mammalian
bacteri
sialidas
glycoform
tasmanian
echidna
platypu
milk
pool
analyz
milk
oligosaccharid
found
abund
sialyllactos
compris
major
acid
oligosaccharid
given
sialidas
activ
inhibit
author
suggest
platypus
adopt
defens
strategi
countermeasur
pathogen
mediat
catabol
sitespecif
oacetyl
sia
impart
select
biolog
function
certain
neuraminidas
andor
esteras
activ
recogn
oacetyl
group
sia
posit
presenc
acetyl
group
provid
ad
steric
block
bacteri
neuraminidas
viral
neuraminidas
activ
remain
unalt
exampl
highlight
potenti
modifi
certain
posit
sia
induc
specif
function
vonitzstein
cowork
develop
ration
design
inhibitor
sialidas
influenza
b
virus
aid
xray
crystallographi
grid
calcul
determin
substitut
basic
function
group
would
form
favor
interact
glu
activ
site
given
sialidas
bind
sia
boat
conform
modifi
sia
unsatur
form
bear
guanidin
group
inhibit
sialidas
influenza
viru
b
viru
valu
nm
nm
respect
work
extend
inhibit
sialidas
human
parainfluenza
viru
hpiv
type
hpiv
classifi
famili
paramyxovirida
contain
hn
fusion
protein
xray
crystal
structur
deduc
revel
hollow
region
near
led
substitut
variou
alkyl
group
consequ
oethyl
group
gave
best
valu
zanamivir
contain
group
also
inhibit
strain
sialidas
valu
valid
inhibit
sialidas
respond
specif
group
ration
design
consist
find
pepper
sialidas
respons
treatment
appear
select
across
speci
find
ultim
led
develop
oseltamivir
tradenam
tamiflu
basel
switzerland
zanamivir
tradenam
relenza
london
uk
howev
advers
effect
low
efficaci
led
decreas
clinic
use
thu
effort
develop
inhibitor
sialidas
therapeut
target
investig
activ
current
extract
method
give
inadequ
yield
thu
synthet
effort
obtain
oacetyl
sia
pure
form
valuabl
use
convent
synthet
approach
seri
monooacetyl
synthes
includ
conjug
synthes
pure
monomer
form
without
acetyl
migrat
anomer
thu
serv
use
standard
delv
deeper
studi
relat
partial
oacetyl
recent
seri
partial
oacetyl
synthes
use
regioselect
exchang
technolog
reset
laboratori
take
advantag
reactiv
variou
silyl
ether
reset
gener
mono
di
tri
tetraoacetyl
sitespecif
manner
notabl
synthes
four
step
yield
improv
effici
previou
report
synthesi
stepeconom
methodolog
reset
offer
access
diverg
librari
oacetyl
effici
pure
form
chemic
modif
sia
report
elsewher
advanc
esteras
toler
synthet
effici
sialidas
inhibitor
could
lead
novel
therapeut
without
lose
efficaci
substitut
oacetyl
group
sia
nacetyl
group
minim
loss
migrat
acetyl
group
retain
similar
conform
oester
author
argu
extend
hydroxyl
site
includ
principl
serv
oacetyl
surrog
may
display
signific
sialidas
inhibit
lead
compound
gener
use
ration
drug
design
interfac
synthet
chemistri
xray
crystallographi
silico
studi
particularli
blockad
siasialidas
hold
tremend
therapeut
potenti
chemic
modif
sia
therefor
repres
uniqu
bioinspir
sia
variant
may
tailor
increas
therapeut
efficaci
antivir
molecul
modifi
sia
specif
oacetyl
isoform
recogn
receptor
determin
viru
pathogenesi
oacetyl
common
form
postglycosyl
modif
sia
mammalian
cell
mediat
specif
soat
oacetyl
occur
sia
highli
regul
welldefin
manner
yet
structur
elucid
oacetyl
sia
remain
incomplet
biolog
implic
recent
garner
greater
attent
modern
extract
method
still
remain
challeng
captur
target
molecul
complex
biolog
mixtur
suffici
amount
method
isol
sitespecif
oacetyl
sialic
acid
high
puriti
need
given
poor
stabil
current
extract
techniqu
spontan
acetyl
migrat
add
structur
complex
synthet
access
oacetyl
sia
high
puriti
remain
valuabl
tool
discoveri
oacetyl
sia
major
receptor
determin
viru
pathogenesi
provid
uniqu
opportun
develop
therapeut
specif
modif
may
enhanc
sialidas
inhibitor
activ
tabl
use
chemic
methodolog
reset
extend
instal
chemic
group
tailor
improv
efficaci
furthermor
chemic
handl
modif
would
much
feasibl
modif
sinc
intramolecular
complic
acetyl
migrat
scarc
differ
class
virus
infect
host
cell
use
glycoprotein
eg
ha
hef
aid
receptor
bind
destroy
function
viral
famili
includ
orthomyxovirida
paramyxovirida
adenovirida
util
sia
host
membran
recognit
molecul
attach
entri
howev
subset
human
pathogen
recogn
oacetyl
sia
includ
influenza
c
although
studi
relat
topic
current
investig
moreov
recognit
oacetyl
isoform
appear
sitespecif
take
account
repres
uniqu
posit
chemic
modif
could
enabl
lead
discoveri
